The question to ask is was BVF in a position to participate; the niche biotech funds have almost certainly had to fund significant redemptions over the last couple of years and must have been faced with cashing out positions in the worst of markets?
Ann: ACW Oversubscribed $3.9 million entitlement offer completed, page-12
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.5¢ | $151.1K | 5.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2007355 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 396794 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |